Tristan van Doormaal, MD, PhD, Neurosurgeon at the University Hospital Zurich (Switzerland) and University Medical Center (UMC) in Utrecht (The Netherlands) and Menno Germans, PhD, neurosurgeon at the University Hospital Zurich (Switzerland) on ENCASE I:
Tristan van Doormaal: ‘This observational clinical study strongly underlines the dedicated preclinical approach: No leakage nor infection was observed within the cohort of 40 patients during the 12 months of clinical follow-up.’
Menno Germans: ‘Moreover, instant usability of the patch is reflected by its ready-to-use, easy to manipulate design and straightforward application. That is the reason why we now use it in our practice’
Tristan van Doormaal: ‘Based on these strong compelling data, ENCASE-1 study criteria were linked to real-world data extracted from 5 different hospitals in Europe and the USA. The retrospective data outcome strongly shows that current used sealants reduce infection at the site of surgery but do not contribute to reduce the CSF leakage as such! This is an important and significant finding which we submitted for publication’.